# Pharmacokinetics of Benapenem in Subjects With Renal Impairment

> **NCT04476407** · PHASE1 · COMPLETED · sponsor: **Sihuan Pharmaceutical Holdings Group Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Complicated Urinary Tract Infection; Cuti

## Interventions

- **DRUG:** benapenem
- **DRUG:** benapenem
- **DRUG:** benapenem

## Key facts

- **NCT ID:** NCT04476407
- **Lead sponsor:** Sihuan Pharmaceutical Holdings Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-15
- **Primary completion:** 2019-10-21
- **Final completion:** 2019-10-21
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04476407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04476407, "Pharmacokinetics of Benapenem in Subjects With Renal Impairment". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04476407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*